Cognitive impairment associated with cocaine use: The role of co-existent alcohol abuse/dependence. 2018

Laura Blanco-Presas, and Ana Moreno-Alcázar, and Silvia Alonso-Lana, and Raymond Salvador, and Edith Pomarol-Clotet, and Peter McKenna
Benito Menni Complex Assistencial en Salut Mental, Barcelona, 08830, Spain.

Cocaine abuse has been reported as leading to impaired cognitive function. However, cocaine abusers commonly also abuse alcohol, which can itself produce cognitive impairment. This study, therefore, aimed to examine the potential confounding effect of alcohol abuse on neuropsychological test performance in cocaine and alcohol abusing individuals, comparing them with individuals who abused alcohol alone and non-abusing controls. Nineteen cocaine abusers who also met DSM-IV criteria for alcohol abuse/dependence (14 m, 5f; mean age 38.65 ± 3.83) and 20 matched individuals who met criteria for alcohol abuse/dependence alone (12 m, 8f; mean age 38.19 ± 4.82) were administered a battery of neuropsychological tests covering executive function, memory, language and visual/visuospatial function after two to four weeks of abstinence. Nineteen matched healthy controls (8 m, 11f; mean age 37.01 ± 5.98) were also tested. Both the cocaine + alcohol group and the alcohol group performed significantly more poorly than the healthy controls on the executive (ESs 2.13 and 2.57) and memory tests (ESs 0.58 and 1.06). The findings were similar for language (ESs 0.92 and 1.69), where the cocaine + alcohol abusers additionally performed significantly better than the alcohol abusers. Both patient groups were impaired on two of the five tests of visual/visuospatial function, with better performance by the cocaine + alcohol group on one of them. Chronic cocaine abuse does not appear from this study to be associated with cognitive impairment over and above that which can be attributed to co-existent alcohol abuse.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D003071 Cognition Intellectual or mental process whereby an organism obtains knowledge. Cognitive Function,Cognitions,Cognitive Functions,Function, Cognitive,Functions, Cognitive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000437 Alcoholism A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4) Alcohol Abuse,Alcoholic Intoxication, Chronic,Ethanol Abuse,Alcohol Addiction,Alcohol Dependence,Alcohol Use Disorder,Abuse, Alcohol,Abuse, Ethanol,Addiction, Alcohol,Alcohol Use Disorders,Chronic Alcoholic Intoxication,Dependence, Alcohol,Intoxication, Chronic Alcoholic,Use Disorders, Alcohol
D056344 Executive Function A set of cognitive functions that controls complex, goal-directed thought and behavior. Executive function involves multiple domains, such as CONCEPT FORMATION, goal management, cognitive flexibility, INHIBITION control, and WORKING MEMORY. Impaired executive function is seen in a range of disorders, e.g., SCHIZOPHRENIA; and ADHD. Executive Control,Executive Controls,Executive Functions,Function, Executive,Functions, Executive
D060825 Cognitive Dysfunction Diminished or impaired mental and/or intellectual function. Cognitive Disorder,Mild Cognitive Impairment,Cognitive Decline,Cognitive Impairments,Mental Deterioration,Cognitive Declines,Cognitive Disorders,Cognitive Dysfunctions,Cognitive Impairment,Cognitive Impairment, Mild,Cognitive Impairments, Mild,Decline, Cognitive,Declines, Cognitive,Deterioration, Mental,Deteriorations, Mental,Disorder, Cognitive,Disorders, Cognitive,Dysfunction, Cognitive,Dysfunctions, Cognitive,Impairment, Cognitive,Impairment, Mild Cognitive,Impairments, Cognitive,Impairments, Mild Cognitive,Mental Deteriorations,Mild Cognitive Impairments

Related Publications

Laura Blanco-Presas, and Ana Moreno-Alcázar, and Silvia Alonso-Lana, and Raymond Salvador, and Edith Pomarol-Clotet, and Peter McKenna
January 2010, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica,
Laura Blanco-Presas, and Ana Moreno-Alcázar, and Silvia Alonso-Lana, and Raymond Salvador, and Edith Pomarol-Clotet, and Peter McKenna
July 1995, Drug and alcohol dependence,
Laura Blanco-Presas, and Ana Moreno-Alcázar, and Silvia Alonso-Lana, and Raymond Salvador, and Edith Pomarol-Clotet, and Peter McKenna
January 2007, The American journal on addictions,
Laura Blanco-Presas, and Ana Moreno-Alcázar, and Silvia Alonso-Lana, and Raymond Salvador, and Edith Pomarol-Clotet, and Peter McKenna
January 1992, Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism,
Laura Blanco-Presas, and Ana Moreno-Alcázar, and Silvia Alonso-Lana, and Raymond Salvador, and Edith Pomarol-Clotet, and Peter McKenna
August 2004, SADJ : journal of the South African Dental Association = tydskrif van die Suid-Afrikaanse Tandheelkundige Vereniging,
Laura Blanco-Presas, and Ana Moreno-Alcázar, and Silvia Alonso-Lana, and Raymond Salvador, and Edith Pomarol-Clotet, and Peter McKenna
November 2010, Alcoholism, clinical and experimental research,
Laura Blanco-Presas, and Ana Moreno-Alcázar, and Silvia Alonso-Lana, and Raymond Salvador, and Edith Pomarol-Clotet, and Peter McKenna
January 2017, Current neuropharmacology,
Laura Blanco-Presas, and Ana Moreno-Alcázar, and Silvia Alonso-Lana, and Raymond Salvador, and Edith Pomarol-Clotet, and Peter McKenna
December 2018, Progress in neuro-psychopharmacology & biological psychiatry,
Laura Blanco-Presas, and Ana Moreno-Alcázar, and Silvia Alonso-Lana, and Raymond Salvador, and Edith Pomarol-Clotet, and Peter McKenna
February 1984, The Medical journal of Australia,
Laura Blanco-Presas, and Ana Moreno-Alcázar, and Silvia Alonso-Lana, and Raymond Salvador, and Edith Pomarol-Clotet, and Peter McKenna
September 2007, Neuropsychology review,
Copied contents to your clipboard!